It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Motoneurons critically depend on precise spatial and temporal control of translation for axon growth and the establishment and maintenance of neuromuscular connections. While defects in local translation have been implicated in the pathogenesis of motoneuron disorders, little is known about the mechanisms regulating axonal protein synthesis. Here, we report that motoneurons derived from Hnrnpr knockout mice show reduced axon growth accompanied by lowered synthesis of cytoskeletal and synaptic components in axons. Mutant mice display denervated neuromuscular junctions and impaired motor behavior. In axons, hnRNP R is a component of translation initiation complexes and, through interaction with O-linked β-N-acetylglucosamine (O-GlcNAc) transferase (Ogt), modulates O-GlcNAcylation of eIF4G. Restoring axonal O-GlcNAc levels rescued local protein synthesis and axon growth defects of hnRNP R knockout motoneurons. Together, these findings demonstrate a function of hnRNP R in controlling the local production of key factors required for axon growth and formation of neuromuscular innervations.
HnRNP R regulates the axonal transcriptome. Here the authors show that hnRNP R is a component of translation initiation complexes and interacts with O-linked β-N-acetylglucosamine (O-GlcNAc) transferase (Ogt), promoting O-GlcNAcylation of eIF4G.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 University Hospital Wuerzburg, Institute of Clinical Neurobiology, Wuerzburg, Germany (GRID:grid.411760.5) (ISNI:0000 0001 1378 7891)
2 Max Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X)
3 University of Wuerzburg, Department of Biochemistry, Theodor Boveri Institute, Wuerzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
4 University of Wuerzburg, Core Unit Systems Medicine, Wuerzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
5 Max Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); University of Copenhagen, NNF Center for Protein Research, Faculty of Health Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)